Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56


Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract.

Garcia GE, Nicole A, Bhaskaran S, Gupta A, Kyprianou N, Kumar AP.

Neoplasia. 2006 Jun;8(6):523-33.


Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.

Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A.

Clin Cancer Res. 2006 Jul 1;12(13):4018-26.


Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL Jr, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK; AACR Task Force on Cancer Prevention.

Clin Cancer Res. 2006 Jun 15;12(12):3661-97. Review.


Cancer statistics, 2006.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ.

CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30.


2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.

Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):980-8.


A prospective study of lycopene and tomato product intake and risk of prostate cancer.

Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):92-8.


Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.

McCabe MT, Low JA, Daignault S, Imperiale MJ, Wojno KJ, Day ML.

Cancer Res. 2006 Jan 1;66(1):385-92.


Regulation of cyclin D2 and the cyclin D2 promoter by protein kinase A and CREB in lymphocytes.

White PC, Shore AM, Clement M, McLaren J, Soeiro I, Lam EW, Brennan P.

Oncogene. 2006 Apr 6;25(15):2170-80.


Role of diet in prostate cancer development and progression.

Chan JM, Gann PH, Giovannucci EL.

J Clin Oncol. 2005 Nov 10;23(32):8152-60. Review.


CREB: the unindicted cancer co-conspirator.

Conkright MD, Montminy M.

Trends Cell Biol. 2005 Sep;15(9):457-9. Review.


Tomatoes or lycopene: a role in prostate carcinogenesis?

Clinton SK.

J Nutr. 2005 Aug;135(8):2057S-9S. Review. No abstract available.


Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CA Jr.

JAMA. 2005 Jul 6;294(1):66-70.


A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Choan E, Segal R, Jonker D, Malone S, Reaume N, Eapen L, Gallant V.

Urol Oncol. 2005 Mar-Apr;23(2):108-13.


Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP).

Mentor-Marcel R, Lamartiniere CA, Eltoum IA, Greenberg NM, Elgavish A.

J Nutr. 2005 May;135(5):989-95.


The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.

Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, Rao NP, Landaw EM, Sakamoto KM.

Cancer Cell. 2005 Apr;7(4):351-62.

Supplemental Content

Support Center